Author: De Greef, Julien; Scohy, Anaïs; Zech, Francis; Aboubakar, Frank; Pilette, Charles; Gerard, Ludovic; Pothen, Lucie; Yildiz, Halil; Belkhir, Leïla; Yombi, Jean Cyr
Title: Determinants of IgG antibodies kinetics after severe and critical COVIDâ€19 Cord-id: k2oth5is Document date: 2021_5_12
ID: k2oth5is
Snippet: The kinetics of IgG antibodies after coronavirus disease 2019 (COVIDâ€19) remain poorly understood. We investigated factors influencing severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2) IgG antibody levels and time to seronegativation during the followâ€up of severe and critically ill patients. We retrospectively reviewed serological evaluations drawn during the followâ€up of severe or critical laboratoryâ€proven COVIDâ€19 patients hospitalized at a large academic hospital. S
Document: The kinetics of IgG antibodies after coronavirus disease 2019 (COVIDâ€19) remain poorly understood. We investigated factors influencing severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2) IgG antibody levels and time to seronegativation during the followâ€up of severe and critically ill patients. We retrospectively reviewed serological evaluations drawn during the followâ€up of severe or critical laboratoryâ€proven COVIDâ€19 patients hospitalized at a large academic hospital. Specific IgG titers were measured using a chemiluminescent assay targeting antiâ€spike and antiâ€nucleocapsid protein IgG. The influence of time, demographic factors, clinical and paraclinical characteristics, and COVIDâ€19 therapeutics on IgG levels were assessed through linear regression using a mixedâ€effect model, and delay until IgG negativation through a Weibull regression model. The cohort included 116 patients with a total of 154 IgG measurements drawn at a median of 79 days after diagnosis. IgG antibodies were increased with age (p = 0.005) and decreased significantly over time (p = 0.0002). Using elapsed time and age as covariates, we demonstrated higher IgG levels in patients with a higher body mass index (BMI) (p = 0.0026) and lower IgG levels in immunocompromised patients (p = 0.032). A high BMI was further found to delay and immunodeficiency to hasten significantly seronegativation, whereas no significant effect was observed with corticosteroids. These data highlight the waning over time of IgG antibodies after severe or critical COVIDâ€19. Age, BMI, and immunosuppression also appear to influence the IgG kinetics, while shortâ€term corticotherapy does not. Those data improve the understanding of SARSâ€CoVâ€2 serology while further research should determine the determinants of longâ€term seroprotection.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date